"Parathyroid Hormone" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A polypeptide hormone (84 amino acid residues) secreted by the PARATHYROID GLANDS which performs the essential role of maintaining intracellular CALCIUM levels in the body. Parathyroid hormone increases intracellular calcium by promoting the release of CALCIUM from BONE, increases the intestinal absorption of calcium, increases the renal tubular reabsorption of calcium, and increases the renal excretion of phosphates.
| Descriptor ID |
D010281
|
| MeSH Number(s) |
D06.472.699.590 D12.644.548.587
|
| Concept/Terms |
Parathyroid Hormone- Parathyroid Hormone
- Hormone, Parathyroid
- PTH (1-84)
- Parathyroid Hormone (1-84)
- Parathormone
- Parathyrin
|
Below are MeSH descriptors whose meaning is more general than "Parathyroid Hormone".
Below are MeSH descriptors whose meaning is more specific than "Parathyroid Hormone".
This graph shows the total number of publications written about "Parathyroid Hormone" by people in this website by year, and whether "Parathyroid Hormone" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 1 | 0 | 1 |
| 2001 | 1 | 0 | 1 |
| 2003 | 1 | 0 | 1 |
| 2004 | 1 | 0 | 1 |
| 2005 | 0 | 1 | 1 |
| 2007 | 0 | 1 | 1 |
| 2008 | 1 | 0 | 1 |
| 2009 | 0 | 1 | 1 |
| 2010 | 0 | 1 | 1 |
| 2012 | 1 | 0 | 1 |
| 2014 | 1 | 1 | 2 |
| 2015 | 1 | 0 | 1 |
| 2016 | 0 | 1 | 1 |
| 2019 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
| 2021 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Parathyroid Hormone" by people in Profiles.
-
Sclerostin antibody improves phosphate metabolism hormones, bone formation rates, and bone mass in adult Hyp mice. Bone. 2022 01; 154:116201.
-
Early biochemical response to parathyroidectomy for primary hyperparathyroidism and its predictive value for recurrent hypercalcemia and recurrent primary hyperparathyroidism. Surgery. 2021 01; 169(1):120-125.
-
Intraoperative parathyroid hormone levels =40 pg/mL are associated with the lowest persistence rates after parathyroidectomy for primary hyperparathyroidism. Surgery. 2019 07; 166(1):50-54.
-
Reoperative Surgery in Patients with Multiple Endocrine Neoplasia Type 1 Associated Primary Hyperparathyroidism. Ann Surg Oncol. 2016 12; 23(Suppl 5):701-707.
-
Prevalence of Hyperparathyroidism, Mineral and Bone Disorders in Children with Advanced Chronic Kidney Disease. Indian J Pediatr. 2016 May; 83(5):420-5.
-
Bone Matrix Composition Following PTH Treatment is Not Dependent on Sclerostin Status. Calcif Tissue Int. 2016 Feb; 98(2):149-57.
-
The biochemical severity of primary hyperparathyroidism correlates with the localization accuracy of sestamibi and surgeon-performed ultrasound. J Am Coll Surg. 2014 Nov; 219(5):1010-9.
-
Pharmacologic augmentation of implant fixation in osteopenic bone. Curr Osteoporos Rep. 2014 Mar; 12(1):55-64.
-
The effects of PTH, loading and surgical insult on cancellous bone at the bone-implant interface in the rabbit. Bone. 2013 Feb; 52(2):718-24.
-
Calcimimetics versus parathyroidectomy for treatment of primary hyperparathyroidism: retrospective chart analysis of a prospective database. Ann Surg. 2012 May; 255(5):981-5.